{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:57Z","timestamp":1790657997159,"version":"4.1.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Hereditary pancreatitis (HP) is a rare autosomal dominant disorder characterized by recurrent episodes of pancreatic inflammation leading to chronic pancreatic damage. We report a 38-year-old Chinese male with a heterozygous cystic fibrosis transmembrane conductance regulator (\n                    <jats:italic>CFTR<\/jats:italic>\n                    ) intronic variant (c.1210-11T&amp;gt;G) who presented with pancreatic diabetes (type 3c diabetes) and an otherwise \u201csilent\u201d pancreatic phenotype. He had a family history of similar manifestations (father and brother with pancreatogenic diabetes). Genetic testing identified the\n                    <jats:italic>CFTR<\/jats:italic>\n                    c.1210-11T&amp;gt;G variant, which is known to affect splicing (TG12-5T allele). The variant meets ACMG criteria for pathogenicity. Segregation analysis confirmed all affected relatives carried this variant. No other significant genetic findings (e.g.\n                    <jats:italic>SPINK1<\/jats:italic>\n                    ,\n                    <jats:italic>PRSS1<\/jats:italic>\n                    ) were detected. The patient\u2019s presentation was dominated by diabetes with minimal abdominal symptoms; however, pancreatic imaging revealed changes consistent with chronic pancreatitis (pancreatic atrophy and ductal irregularity). The diagnosis of hereditary chronic pancreatitis was established based on clinical, imaging and genetic criteria. In the Discussion, we compare this case to reported\n                    <jats:italic>CFTR<\/jats:italic>\n                    -related pancreatitis cases and highlight the importance of considering\n                    <jats:italic>CFTR<\/jats:italic>\n                    variants in familial idiopathic pancreatitis with diabetes. This case underscores that\n                    <jats:italic>CFTR<\/jats:italic>\n                    single heterozygous variants (especially bicarbonate-defective alleles) can cause a pancreatitis-predominant phenotype. It also emphasizes the need for comprehensive genetic testing in atypical diabetes.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2026.1907178","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:44:40Z","timestamp":1790657080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CFTR variant-associated hereditary pancreatitis complicated by diabetes mellitus: a case report and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhenzhen","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Huian County General Hospital","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2023.0367","article-title":"Etiology, diagnosis, and modern management of chronic pancreatitis: A systematic review","volume":"158","author":"Cohen","year":"2023","journal-title":"JAMA Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2025.08.005","article-title":"Type 3c diabetes associated with chronic pancreatitis: A narrative review","volume":"25","author":"Rasheed","year":"2025","journal-title":"Pancreatology Off J Int Assoc Pancreatology (IAP)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-s244","article-title":"Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed","volume":"31","author":"Hardt","year":"2008","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300645","article-title":"CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: Is the role of mutated CFTR overestimated","volume":"62","author":"Rosendahl","year":"2013","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41424-018-0069-5","article-title":"SPINK1, PRSS1, CTRC, and CFTR genotypes influence disease onset and clinical outcomes in chronic pancreatitis","volume":"9","author":"Zou","year":"2018","journal-title":"Clin Trans Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000846","article-title":"Prevalence of CFTR pathogenic variants in pancreatitis: A systematic review and meta-analysis","volume":"16","author":"Jiang","year":"2025","journal-title":"Clin Trans Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276397","article-title":"Bicarbonate defective CFTR variants increase risk for chronic pancreatitis: A meta-analysis","volume":"17","author":"Berke","year":"2022","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ng0893-426","article-title":"Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels","volume":"4","author":"Delaney","year":"1993","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/9781118997505.ch49","article-title":"Common CFTR haplotypes and susceptibility to chronic pancreatitis and congenital bilateral absence of the vas deferens","volume":"32","author":"Steiner","year":"2011","journal-title":"Hum Mutat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.13.2339","article-title":"Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9","volume":"8","author":"Niksic","year":"1999","journal-title":"Hum Mol Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004376","article-title":"Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis","volume":"10","author":"LaRusch","year":"2014","journal-title":"PloS Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/s1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cystic Fibrosis Off J Eur Cystic Fibrosis Soc"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2013.05.002","article-title":"Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: Recommendations from PancreasFest 2012","volume":"13","author":"Rickels","year":"2013","journal-title":"Pancreatology Off J Int Assoc Pancreatology (IAP)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf623","article-title":"Approach to the patient with pancreatogenic diabetes","volume":"111","author":"Ode","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00070","article-title":"Pancreatic cancer risk in hereditary pancreatitis","volume":"5","author":"Weiss","year":"2014","journal-title":"Front Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41598-022-26411-8","article-title":"Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: Defining the optimal subgroup for surveillance","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1907178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:44:51Z","timestamp":1790657091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1907178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":17,"alternative-id":["10.3389\/fendo.2026.1907178"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1907178","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1907178"}}